-
1 Comment
China Tian Yuan Healthcare Group Limited is currently in a long term uptrend where the price is trading 68.6% above its 200 day moving average.
From a valuation standpoint, the stock is 98.5% more expensive than other stocks from the Consumer Cyclical sector with a price to sales ratio of 9.6.
Based on the above factors, China Tian Yuan Healthcare Group Limited gets an overall score of 1/5.
ISIN | KYG8442J1004 |
---|---|
Industry | Medical Care Facilities |
Sector | Healthcare |
Exchange | HK |
CurrencyCode | HKD |
PE Ratio | None |
---|---|
Target Price | None |
Beta | 0.4 |
Market Cap | 319M |
Dividend Yield | None |
China Tian Yuan Healthcare Group Limited, an investment holding company, provides healthcare related services in Hong Kong, Korea, the People's Republic of China, and Korea. It operates through Investment Holding, Healthcare, Money Lending and Related Business, and Hospitality segments. The company offers procurement, marketing, and management services to the medical industry; and plastic surgery and medical beauty services, as well as licenses trademarks. It also invests in equity investments; offers loans and related services; refers and introduces lenders and borrowers; and provides procurement services to the hospitality industry. The company was formerly known as City e-Solutions Limited and changed its name to China Tian Yuan Healthcare Group Limited in November 2017. The company was incorporated in 1990 and is based in Wan Chai, Hong Kong. China Tian Yuan Healthcare Group Limited is a subsidiary of Tian Yuan Manganese Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0557.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025